Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists
Details for Australian Patent Application No. 2003202343 (hide)
International Classifications
Event Publications
3 April 2003 Complete Application Filed
Priority application(s): 60/351,384 24.01.02 US
18 September 2003 Application Open to Public Inspection
Published as AU-B-2003202343
16 March 2006 Assignment before Grant
Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.
12 July 2007 Application Accepted
Published as AU-B-2003202343
9 August 2007 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 23 Jul 2007. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
15 November 2007 Standard Patent Sealed
3 January 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 23 Jul 2007
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003202344-SIGNALLING APTAMER COMPLEXES
2003202342-WINDOW REGULATOR HAVING GUIDED COUNTER BALANCE SPRING
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser